Article
Diagnostic significance of antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary oral hypoglycemic agents failure.
Clinical immunology and immunopathology - 1 Nov 1997
Fukui M, Nakano K, Maruya E, Saji H, Ohta K, Ohta M, Obayashi H, Mori H, Kajiyama S, Wada S, Shigeta H, Kitagawa Y, Nakamura N, Kondo M
Abstract excerpt
Some non-insulin-dependent diabetes mellitus (NIDDM) patients are positive for antibodies to glutamic acid decarboxylase (anti-GAD), and they tend to develop insulin deficiency. The aim of this study was to evaluate the prevalence of anti-GAD in NIDDM with secondary failure of sulfonylurea agents (NIDDM-SF) and to investigate the diagnostic significance of seropositivity for anti-GAD in NIDDM-SF patients by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.